tirzepatide super obesity bmi 60 More than 1 in 4 adults with had a novel physiologic subtype marked by fast gastric emptying, discordantly low postmeal GLP‑1 levels, and increased postmeal hunger. In a retrospective analysis, participants Multi-modal neo-adjuvant anti-obesity medications may

The Gila Monster + GLP-1 Connection: How a Lizard Changed Modern Medicine Jennifer Hardy Apr 20, 2025 4 min read While the advent of the Ozempic Era is widely credited to Big Pharma companies like Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide), it turns out the real GLP-1 game changer is one of the most venomous and elusive lizards on Earth: the Gila monster

Our most comprehensive program for optimal results

SGLT2 inhibitors in resistant hypertension: a sweet solution

This should be discussed during a consultation

Effectiveness of MIC and B12 injections in weight loss

Personalization is crucial, as individual preferences, lifestyle, and health conditions are critical in deciding the best option